Avarax
Latest round
- Seed
Last raised
- Nov 2015
Total raised
- $3.5M
Investors
- 1
About Avarax
Based in Australia, Avarax is a developer of vaccine for peanut allergies.
Who invested in Avarax
1 investor across 1 round
See all investors in Avarax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Nov 23, 2015
Amount
$3.5M
Investors
Questions about Avarax
Who invested in Avarax?
Avarax has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Avarax raised?
Avarax has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Avarax last raise money?
Avarax's most recent round on record is a Seed, in Nov 2015.
What does Avarax do?
Based in Australia, Avarax is a developer of vaccine for peanut allergies.
Where is Avarax headquartered?
Avarax is headquartered in Australia.
Which VCs invest in companies like Avarax?
Among active investors with capital left to deploy, Blackbird, AirTree Ventures, Square Peg and Immutable Ventures back pharmaceuticals companies at Avarax's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Seed
Raising like Avarax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.